KFDA to approve GSK's Requip.
Requip was authorized by the U. S. FDA to sell in May this year for the treatment of moderate-to-s...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
